Content Section
In this undated photo released by German drug and chemical maker Merck KGaA an employee controls samples in the molecular biology department. German drug maker Merck KGaA said Wednesday, April 25, 2007 it lost euro 8.3 million (US$ 11.3 million) in the first quarter, reflecting the cost of the acquisition of Swiss biotechnology company Serono. (AP Photo/Merck) ** EDITORIAL USE ONLY * MANDATORY CREDIT ** AP Photo